2433/MS/EXP/D-847 671/EYE(DRUG)/IFA RE-283/2024-25

Dept of Eye

Nepafenac 0.3% w/v Eye Drops with Benzalkonium Chloride Solution (As preservative) NF 0.01% v/v Sterile Aqueous base q.s

Hydroxy propyl methyl cellulose ophthalmic solution 2% intraocular use PFS 3ml glass syringe with cannula (22G)

Sodium Hyaluronate BP 0.18% w/v pharma grade GS 100 with endotoxin units lesser than 0.5EU/mg in sterile Aqueous base q-s. Eye drops with pure flow technology, blue tip for accuracy in drop delivery and can be used for 60 days in 10ml pack (preservative free)

Cyclosporine Ophthalmic solution 0.09% w/v (1*10 single-use vial of 0.25 ml sterile, preservative free)

Brinzolamide 1% w/v Timolol Maleate 0.5% w/v Ophthalmic Suspension (BAK FREE) Preserved with Potassium Sorbate 0.47

Latanoprost 0.005%, 2.5ml (Eye Drop)

Bimatoprost 0.03% bott of 3ml

Olopatadine HCL 0.1% E/D

Tropicamide 0.8% with 5% Phenylephrine eye drop bott of 5 ml

Proparacaine eyedrop 0.5%,bott of 5 ml.

E/D Nepafenac 0.1% with drop tainer technology .5ml

Dorzolamide and Timolol Eye Drops(Dorzolamide 2% w/v + Timolol 0.5% w/v) in 5ml Dimple Bottle technology

E/dBrimonidine tartarte 0.2% with Timolol maleate0.5%, US FDA Approved

SMPL Life Sciences Pvt. Ltd. (BID ID -3251964)

AKSHAT PHARMA PRIVATE LIMITED (BID ID -3252223)

Medikon India Private Limited (BID ID -3250363)

CONCEPT BIOMEDICAL (BID ID -3252101)

Prakash Medicos (BID ID -3250208)

Medikon India Private Limited

sk life sciences

SMPL Life Sciences Pvt. Ltd.

CONCEPT BIOMEDICAL

AKSHAT PHARMA PRIVATE LIMITED